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ABSTRACT: The aim of this study was to characterize stem and progenitor cell populations from the equine superficial digital flexor
tendon, an energy-storing tendon with similarities to the human Achilles tendon, which is frequently injured. Using published methods
for the isolation of tendon-derived stem/progenitor cells by low-density plating we found that isolated cells possessed clonogenicity but
were unable to fully differentiate towards mesenchymal lineages using trilineage differentiation assays. In particular, adipogenic
differentiation appeared to be restricted, as assessed by Oil Red O staining of stem/progenitor cells cultured in adipogenic medium.
We then assessed whether differential adhesion to fibronectin substrates could be used to isolate a population of cells with broader
differentiation potential. However we found little difference in the stem and tenogenic gene expression profile of these cells
as compared to tenocytes, although the expression of thrombospondin-4 was significantly reduced in hypoxic conditions. Tendon-
derived stem/progenitor cells isolated by differential adhesion to fibronectin had a similar differentiation potential to cells isolated
by low density plating, and when grown in either normoxic or hypoxic conditions. In summary, we have found a restricted
differentiation potential of cells isolated from the equine superficial digital flexor tendon despite evidence for stem/progenitor-like
characteristics.  2015 The Authors. Journal of Orthopaedic Research Published by Wiley Periodicals, Inc. on behalf of Orthopaedic
Research Society. J Orthop Res 33:849–858, 2015.
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INTRODUCTION
Sports participation, occupation, and aging increase
the risk of tendon injury and degeneration in both
humans and animals.1–3 In the horse, the superficial
digital flexor tendon (SDFT) is commonly injured,
resulting in lameness and reduced performance, par-
ticularly in athletic and racing horses.3 SDF tendino-
pathies are more prevalent with age, and age-related
alterations to both fascicles and the interfascicular
matrix of the endotenon alter the response of the
SDFT to mechanical loading.4–6 Tendon injury and
age-related degeneration results in particular patterns
of matrix fragmentation that may affect the structural
integrity of the tendon extracellular matrix and the
microenvironment of tendon cells.7
The identification of a population of cells within
tendon with stem cell-like characteristics8 holds poten-
tial for tendon regeneration. Tendon-derived stem/
progenitor cells (TSPCs) have been identified in hu-
man, mouse,8 rat,9 and rabbit tendon.10 TSPCs possess
similar properties to mesenchymal stem cells (MSCs)
and have been identified by the expression of cell
surface and stem-cell markers, and a capacity for self-
renewal and multi-lineage differentiation. TSPCs are
thought to be tenocyte precursors and can be induced
to differentiate into osteocytes, chondrocytes, and
adipocytes in vitro and in vivo.8–12
In mice, treadmill training has been reported to
increase TSPC proliferation and to increase expression
of the tenogenic marker scleraxis in epitenon fibro-
blasts.13,14 Cells obtained from the peritenon of mouse
Achilles tendon demonstrated decreased clonogenicity
compared to the tendon core and limited osteogenic
differentiation.12 In the equine SDFT, peritenon
cells displayed decreased clonogenicity and both osteo-
genic and adipogenic differentiation, but were reported
to have increased proliferation and increased expres-
sion of progenitor cell markers.15 Tendons are relative-
ly poorly vascularized16 and tendon cells reside within
a hypoxic environment. Culture of TPSCs in 2%
oxygen has been reported to increase proliferation but
to reduce multipotency,17,18 whereas 5% oxygen re-
portedly both increases proliferation and maintains
stemness.19
In this study, we aimed to isolate and characterize
TSPCs from non-diseased samples of the frequently
injured equine superficial digital flexor tendon. The
equine SDFT primarily acts as an energy store during
locomotion and performs a similar role to the human
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Table 1. Primer Sequences
Gene Forward Reverse
CD90 TGCTCCGAGACAAACTGGT CCGAGGTGTGTGAGGGATTG
CD73 CCAGGAAGTGGGGAGAACAC CCAAGGTAATGGTGCCGTTG
TNC GTTTCAGATGCCACCCCAGA AGCCCATAGCTGTTGTTGCT
SCX TCTGCCTCAGCAACCAGAGA TCCGAATCGCCGTCTTTC
MKX GATGACGCTAGTGCAGGTGT CCCCCTTCGTTCATGTGGTT
EGR-1 CCACCATGGACAACTACCCT ATGTCAGGAAAAGACTCTGAGG
DCN GTCACAGAGCAGCACCTACC TCACAACCAAGGAACCTTTTAATCC
OCT4 GAGAAGGACGTGGTACGAGTG GTGCCAGGGGAAAGGATACC
NANOG CAGGGGATCTTCACCAGTGC GGAAGGCAGAGGAGAGACAGT
TNMD ACGTGACCATGTATTGGATCAATC CACCATCCTCCTCAAAGTCTTGT
THBS4 AATCCTGACAGACCCCACCC GGTAGCGGAGGATGGCTTTGTT
FABP4 CAGAGGGTCAGAGCACCTTC GCCCACTCCCACTTCTTTCA
PPARg ATGGGTGAAACTCTGGAAGATT GGTAATTTCTTGTGAAGTGCTTGC
LEP CATTGAAGCTGTGCCCATCC AGACTGACTGCGTGTGTGAAA
RUNX2 GTGGACGAGGCAAGAGTTTC TGAGGCGGTCAGAGAACAAA
OMD CAAATTCATCAACCCCTGAAA CTTCATCTGGCTCTTGGTCA
ALP GGGTAGCAGCCAGTTCAGTT GGGATCTTTCTCTTTCTCTGGCA
COL1A1 CATGTTCAGCTTTGTGGACCT TGACTGCTGGGATGTCTTCTT
DCN GTCACAGAGCAGCACCTACC TCACAACCAAGGAACCTTTTAATCC
SOX9 AGCAGACACACATCTCCCCC GCGAGGAATGAGCCTACAAGGT
COL2A1 TGAGCCATGATACGCCTCG CTCCTTTCTGTCCCTTCGGT
ACAN GCGGTACGAGATCAACTCCC CTTGTAGCTGGCGGGGTC
GAPDH GCATCGTGGAGGGACTCA GCCACATCTTCCCAGAGG
Figure 1. Comparison of the colony forming ability and marker gene expression of tenocytes and tendon-derived stem/progenitor cells
(TSPCs) isolated by low-density plating. A: Colony formed from TSPCs after low-density plating. B: Crystal violet staining of colonies
formed from TSPCs seeded at 10 cells/cm2 after 1 passage. Bar; 1 cm. C: Crystal violet staining of colonies formed from tenocytes seeded
at 10 cells/cm2 after the first passage. D: Number of colonies formed from tenocytes and TSPCs seeded at 100 cells/cm2 after the first
passage in T25 flasks. E: Relative expression of stem/progenitor and tenogenic genes as compared to B2M housekeeper in tenocytes
(dark gray bars) and TSPCs (light gray bars) isolated by low-density plating (n¼ 6, mean age 11.0 years, range 1–22 years). Error bars
represent SEM. *p¼0.00298, ap¼ 0.0249, bp¼0.0115, cp¼0.00895, dp¼0.017.
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Figure 2. Trilineage differentiation assay for TSPCs isolated by low density plating at 80 cells/cm2 (A–F) or by plating onto substrates
precoated with 1mg/ml fibronectin (G–L). A, B and G, H: Representative images of TSPCs grown in control (A, G) and osteogenic
induction media (B, H) and stained with Alizarin Red. Sample age 6 years. Bar; 100mm. C, D and I, J: Representative images of TSPCs
grown in control (C, I) and adipogenic induction media (D, J) and stained with Oil Red O. No staining was detected. Sample age
6 years. Bar; 100mm. E, F and K, L: Representative images of TSPCs pellet cultures grown in control (E, K) and chondrogenic
induction media (F, L) and stained with Alcian Blue. Sample ages 8 years (E, F), 6 years (K, L). Bar; 5mm. M: Relative expression of
osteogenic markers as compared to B2M housekeeper for TSPCs isolated by low density plating (n¼4, mean age 7.5 years, range 2–14
years) (solid fill) or by differential adhesion to fibronectin (n¼3, mean age 7.7 years, range 2–15 years) (hatched fill) and grown in
control (dark gray bars) or osteogenic induction media (light gray bars). N: Relative expression of adipogenic markers as compared to
B2M housekeeper for TSPCs isolated by low density plating (n¼ 3, mean age 9.7 years, range 6–15 years) (solid fill) or by differential
adhesion to fibronectin (n¼ 3, mean age 7.7 years, range 2–15 years) (hatched fill) and grown in control (dark grey bars) or adipogenic
induction media (light gray bars). O: Relative expression of chondrogenic markers as compared to B2M housekeeper for TSPCs isolated
by low density plating (n¼ 3, mean age 5.3 years, range 2–8 years) (solid fill) or by differential adhesion to fibronectin (n¼3, mean age
7.7 years, range 2–15 years) (hatched fill) and grown in control (dark gray bars) or chondrogenic induction media (light gray bars).
Error bars represent SEM. a–cPair-wise comparisons: ap¼0.0414, bp¼ 0.0460, cp¼0.0019. d–o2-way ANOVA: dp¼ 0.03, ep¼0.037,
fp<0.001, gp<0.001, hp¼0.003, ip¼ 0.003, jp¼0.006, kp¼0.014, lp¼0.016, mp¼ 0.02, np¼ 0.018, op¼0.007.
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Achilles. We hypothesized that multipotent TSPCs
would be present in the equine SDFT as they have
previously been identified in tendon from other spe-
cies. However, injured tendons have limited capacity
for healing and tissue regeneration, despite the
reported presence of TSPCs in tendon.
METHODS
Isolation of TSPCs and Tenocytes
Superficial digital flexor tendon (SDFT) was harvested from
equine cadavers (age range 1–22) obtained from a UK
abattoir. Tissue samples were grossly normal upon examina-
tion. The mid-substance tendon tissue, without the paratenon/
tendon sheath, was dissected in to small pieces and digested
overnight at 37˚C in 1mg/ml collagenase II. The resulting cell
suspension was strained and then centrifuged at 2,300rpm for
10min and the supernatant discarded. The cells were resus-
pended in complete Dulbecco’s modified Eagle’s medium
(DMEM) (DMEM with GlutaMAX supplemented with 10%
foetal calf serum, penicillin [100U/ml]), streptomycin (100mg/
ml), and amphotericin B [2mg/ml]), and counted using a
haemocytometer. The same batch of foetal calf serum was
used for all experiments. For tenocyte isolation, the cells were
seeded at 2.8 104 cells/cm2 and for TSPC isolation the cells
were seeded at 10, 80, or 100 cells/cm2. The cells were cultured
at 37˚C, 5% CO2 and either 21%, or 5% O2 for 10–12 days.
Colonies were detached using trypsin and transferred to T25
culture flasks. For differential fibronectin, adhesion cells were
seeded at 1,200 cells/cm2 after digestion, onto plates previously
coated with either 1 or 20mg/ml human fibronectin, and the
media replaced after 20min. Cells grown on substrates pre-
coated with 20mg/ml human fibronectin were supplemented
with 5ng/ml FGF-2. After 6–8 days the cells were confluent
and transferred to a T25 culture flask.
Colony Forming and Tri-Lineage Differentiation Assays
Tenocytes or TSPCs isolated by low-density plating were
seeded at 10 cells/cm2 after the first passage and colonies
stained with crystal violet before imaging whole wells with a
camera or using a Nikon Eclipse TS100 microcope attached
to a Nikon Digital Sight CCD camera. For differentiation
assays cell monolayers at passage 2 were cultured for
21 days in osteogenic induction media (complete DMEM
containing 100nM dexamethasone, 10mM b-glycerophos-
phate, and 0.5mM ascorbic acid) or adipogenic induction
media (complete DMEM containing 1mM dexamethasone,
100mM indomethacin, 10mg/ml insulin, and 500mM isobutyl-
methylxanthine). Cell pellets were cultured for 21 days in
chondrogenic induction media (complete DMEM containing
100nM dexamethasone, 25mg/ml ascorbic acid, 10ng/ml
TGF-b, and ITSþ3 media supplement [Sigma-Aldrich, Gil-
lingham, UK]). Control cells were cultured in complete
DMEM with or without phenol red. Cells were stained with
alizarin red to assess osteogenic differentiation,20 Oil Red O
to assess adipogenic differentiation,21 and alcian blue for
chondrogenic differentiation22 as described in the PromoCell
MSC application notes. RNA was extracted from all assays to
analyze lineage-specific gene expression.
RNA Extraction and Quantitative RT-PCR
RNA was extracted with Trizol and using a cell scraper for
cell detachment and by repeated pipetting to disrupt cell
pellets. TSPCs were analyzed at passage 1–2. cDNA was
synthesized in a 25ml reaction from 1–2mg of total RNA by
incubation for 5min at 70˚C, 60min at 37˚C, and 5min at
93˚C using M-MLV reverse transcriptase and random-
hexamer oligonucleotides (Promega Ltd., Southampton, UK).
qRT-PCR was conducted using a GoTaq(R) qPCR Master Mix
(Promega). A total of 10ng of cDNA was amplified in a 25ml
reaction using an AB 7300 Real Time PCR System (Life
Technologies Ltd., Paisley, UK). Equine specific gene-specific
primers were used (Table 1) and GAPDH or B2M (Primer
Design, Southampton, UK, proprietary sequence) used as
internal controls. After an initial denaturation for 10min at
95˚C, 40 PCR cycles were performed consisting of 15 s at
95˚C and 1min at 60˚C. Relative gene expression was
calculated according to the comparative Ct method.
23
Flow Cytometry
TSPCs at passage 1–2 were detached using Accutase (Life
Technologies Ltd., Paisley, UK) and counted. Aliquots contain-
ing 1 106 cells were blocked with 10% normal serum in FACS
buffer (2.5% FBS in PBS) for 20min before washing. Cells were
resuspended in either fluorescently conjugated or unconjugated
primary antibodies for 45min at 4˚C. Anti-CD90 (ab225,
Abcam, Cambridge, UK), anti-CD105 (MCA1557A488T, Sero-
tec, Oxford, UK), and anti-CD73 (550256, BD Biosciences,
Oxford, UK) were used in this study. Cells were washed and
either analyzed directly (CD105) by flow cytometry (BD Acurri
C6 flow cytometer, BD Biosciences, Oxford, UK) or incubated
with a secondary antibody for a further 45min at 4˚C (CD90
and CD73) before washing and analysis. Cells in the absence of
antibody and in the presence of the secondary antibody only
were used as controls. A threshold gating out at least 95.5% of
the control cells was used and for samples including primary
antibody the percentage of positive cells calculated as that
exceeding the threshold.
Cell Proliferation Assay
Cells were seeded at 133 cells/cm2 at passage 2. At 80%
confluency the cells were counted and the doubling time
calculated.
Figure 3. Comparison of population doubling times of TSPCs
isolated by low-density plating and fibronectin adhesion and
grown in hypoxic conditions. TSPCs were isolated by plating at
10 cells/cm2 or by differential adhesion onto substrates precoated
with 20mg/ml fibronectin (f-TSPCs), grown in 5% oxygen (light
gray bars) and compared to tenocytes. *p¼0.015. Cells grown in
21% (dark gray bars) are shown for comparison however for
TSPCs or f-TSPCs grown in 21% oxygen only two biological
replicates were available (age range 1–22 years). Error bars
represent SEM.
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Statistical Analysis
Statistical analysis was performed using SigmaPlot 12.5. For
pairwise comparisons a t-test was utilized and a Mann–
Whitney rank-sum test used for samples that did not meet the
assumption of normality (Shapiro–Wilk test). For comparisons
of three samples, a one-way ANOVA was used. For compar-
isons across two conditions, a two-way ANOVA was used. For
samples not meeting the assumption of normality for two-way
Figure 4. Flow cytometry analysis of cell surface markers CD90, CD73, and CD105 on tendon-derived stem/progenitor cells isolated
by differential adhesion onto substrates precoated with 20mg/ml fibronectin (f-TSPCs) and grown in normoxia and 5% hypoxia. A–C:
f-TSPCs (age 1 year) grown in 21% oxygen and incubated with control or antibodies (þ) to CD90 (A), CD73 (B), or CD105 (C) for flow
cytometry. D–F: f-TSPCs grown in 5% oxygen and incubated with control or antibodies (þ) to CD90 (D), CD73 (E), or CD105 (F) for
flow cytometry. ap¼ 0.024, bp¼0.04, cp¼ 0.038.
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ANOVA (Shapiro–Wilk test), data were transformed using
either a log base 10 or square root transformation so that the
resulting data sets were normally distributed. Suitable trans-
formations could not be found for BGLAP in Figure 2M or
THBS4 in Figure 5. A Holm–Sidak post-hoc test was used for
two-way ANOVA results where the resulting p value was less
than 0.05.
RESULTS
TSPCs from Equine SDF Tendon form Colonies when Plated
at Low Density but have Restricted Trilineage
differentiation
TSPCs isolated from SDF tendon by low-density
plating were able to form colonies after replating, as
were tenocytes initially plated at high density
(Fig. 1A–C). The number of colonies obtained from
tenocytes was higher than that obtained from TSPCs
(Fig. 1D). TSPCs had increased expression of the
tenogenic markers scleraxis (SCX), early growth re-
sponse 1 (EGR1), and decorin (DCN) but decreased
expression of CD90 (Fig. 1D). Expression of CD34 and
CD144 was low in both tenocytes and TSPCs indicat-
ing the cell populations are not contaminated with
hematopoietic stem cells.
Growth of equine TSPCs in osteogenic media
resulted in Alizarin Red positive nodules (Fig. 2A and
B) but no Oil Red O positive lipid droplets could be
observed in TSPCs grown in adipogenic media (Fig. 2C
and D). Growth of pellet cultures in chondrogenic
media resulted in clearly increased pellet size in 2 of 3
cultures (Fig. 2E and F). For TSPCs grown in osteo-
genic media, there were no significant differences in
the expression of osteogenic markers runx2 (RUNX2),
alkaline phosphatase (ALP), osteocalcin (BGLAP), or
osteomodulin (OMD) in osteogenic as compared to
control media (Fig. 2M). Expression of osterix (SP7)
and osteopontin (SPP1) was low but either significant-
ly increased (SP7) or decreased (SPP1) between control
and osteogenic media. TSPC growth in adipogenic
media did not result in increased expression of leptin
(LEP), FABP4, or PPARg (Fig. 2N) and no statistically
significant differences in chondrogenic gene expression
were found for TSPCs grown in chondrogenic media
(Fig. 2O).
We then considered that low density plating may
not be a suitable method to isolate equine TSPCs and
used differential adhesion to fibronectin as a stem cell
isolation method, as previously described for epidermal
stem cells and cartilage progenitor cells.24,25 Plating
onto substrates precoated with 1mg/ml fibronectin
promoted osteogenic differentiation of TSPCs grown in
osteogenic media as assessed by Alizarin Red staining
(Fig. 2G and H). Adipogenic differentiation was not
detected by Oil Red O staining for TSPCs isolated by
differential fibronectin adhesion and grown in adipo-
genic media (Fig. 2I and J) but chondrogenic differen-
tiation was noted in all pellet cultures of the same
cells grown in chondrogenic media (Fig. 2K and L).
There was no increase in expression of osteogenic
markers (Fig. 2M) but there was a significant increase
in leptin gene expression (Fig. 2N) for adipogenic
cultures and of aggrecan alone for chondrogenic cul-
tures (Fig. 2O).
Putative TSPCs Can Be Isolated by Differential Adhesion to
Fibronectin
In subsequent experiments, substrates precoated with
20mg/ml fibronectin were used and the effect of
normoxia (21% oxygen) and hypoxia (5% oxygen) on
the characteristics of these putative stem cells
(denoted f-TDCSs) analyzed. In hypoxic conditions,
TSPCs isolated by low-density plating proliferated
more slowly than tenocytes or TSPCs isolated by
plating onto substrates precoated with 20mg/ml of
fibronectin (Fig. 3).
Flow cytometry analysis indicated that f-TSPCs
grown in normoxia or hypoxia expressed the cell
surface marker CD90 (Fig. 4A, D, and G). There was
some evidence for low expression of CD73 and CD105
in f-TSPCs grown in hypoxia (Fig. 4B and C, E–G).
By quantitative RT-PCR there were no significant
differences in the expression of stem or progenitor
markers between tenocytes and f-TDSCs (Fig. 5).
Expression of thrombospondin-4, previously reported
to be a tendon-selective marker26 was however signifi-
cantly decreased in f-TDSCs as compared to tenocytes
grown in hypoxia.
Trilineage differentiation assays indicated that f-
TDSCs grown in normoxia or hypoxia were osteogenic
and chondrogenic as assessed by Alizarin Red and
Alcian Blue staining of pellet cultures, respectively
(Fig. 6A–L). No adipogenic differentiation was
detected by Oil Red O staining. Similarly, growth in
hypoxic conditions did not affect the differentiation
capacity of TDSCs isolated by low density plating
which again differentiated to osteogenic and chondro-
genic lineages, in both normoxic and hypoxic condi-
tions, as assessed by Alizarin Red and Alcian Blue
staining (Fig. 6M–X).
Figure 5. Marker gene expression of tenocytes and tendon-
derived stem/progenitor cells isolated by differential adhesion
onto substrates precoated with 20mg/ml fibronectin (f-TSPCs).
Relative expression of stem/progenitor and tenogenic genes as
compared to GAPDH in tenocytes (dark gray bars) and f-TSPCs
(light gray bars) grown in 21% (solid fill) or 5% oxygen (hatched
fill) (n¼4, mean age 9.0 years, range 1–22 years, except f-TSPCS
grown in 21% oxygen; n¼ 3, mean age 9.7 years). Error bars
represent SEM. *p¼0.029.
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The expression of osteogenic, adipogenic, and chon-
drogenic marker genes was determined for TSPCs
isolated by differential adhesion to fibronectin (20mg/
ml) or by low density plating at 10 cells/cm2 and grown
in hypoxic conditions with osteogenic, adipogenic, or
chondrogenic induction media. No consistent altera-
tions in marker gene expression were observed
(Fig. 7).
Figure 6. Trilineage differentiation assay for TSPCs isolated by differential adhesion onto substrates precoated with 20mg/ml
fibronectin (A–L) or by low density plating at 10 cells/cm2 (M–X) and grown in normoxia (A-B, E-F, I-J, M-N, Q-R, U-V) or 5% hypoxia
(C-D, G-H, K-L, O-P, S-T, W-X). A–D and M–P: Osteogenic differentiation assays. TSPCs were grown in control (A, C, M, O) or
osteogenic induction media (B, D, N, P) and stained with Alizarin Red. Bar; 100mm. E–H and Q–T: Adipogenic differentiation assays.
TSPCs were grown in control (E, G, Q, S) or adipogenic induction media (F, H, R, T) and stained with Oil Red O. No staining was
detected. Bar; 100mm. I–L and U–X: Chondrogenic differentiation assays. TSPC pellet cultures were grown in control (I, K, U, W) or
chondrogenic induction media (J, L, V, X, and stained with Alcian Blue. Bar; 5mm. Sample age 1 year.
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DISCUSSION
Using published methods for isolation of TSPCs by
low-density plating8,9 we found that TSPCs from
equine SDFT did not differentiate to the adipogenic
lineage as assessed by Oil Red O staining. We also
found that expression of osteogenic and chondrogenic
marker genes was not entirely consistent with histo-
logical staining techniques for assessing differentia-
tion. Fibronectin has been identified as a suitable
substrate to maintain long term self renewal of
embryonic stem cells and has been used for isolation of
epidermal stem cells and cartilage progenitors.24,25,27
Fibronectin was therefore a good candidate ECM
substrate for differential isolation of tendon stem cells.
However, isolation of putative TSPCs by plating onto
substrates pre-coated with fibronectin, as well as
growth in hypoxic conditions produced similar results
to the low density plating method.
The observed restricted differentiation potential of
isolated TSPCs was surprising as the equine SDFT
potentially contains at least three stem cell niches;
within the collagenous tendon fascicles, within the
loose connective tissue of the endotenon (the interfas-
cicular matrix) and within the vasculature present
within the endotendon. Two previous studies reported
adipogenic differentiation of cells from the SDFT,
when comparing equine tendon cells with bone mar-
row stromal cells28 and comparing cell populations
from the tendon core and peritenon.15 In this study,
we only isolated cells from the tendon core, however, it
is possible that the process of tissue transportation
from the abattoir from which samples were obtained
could adversely affect stem cell viability, leaving a
population of progenitor cells with restricted differen-
tiation potential. We used the same batch of serum for
all experiments and it is possible that the particular
batch did not support adipogenic differentiation. Alter-
natively the process of isolating TSPCs by low density
plating or differential adhesion to fibronectin may
remove a sub-group of cells capable of adipogenic
differentiation from the equine SDFT cell population.
Age has been reported to affect adipogenic differentia-
tion of rat but not human TSPCs.29,30 In this report,
we studied samples ranging from 1 to 22 years (equiv-
alent to age 4–77 in humans) but found no observable
differences in adipogenic differentiation.
We did not find significant differences between the
proliferation rates of tenocytes and putative f-TSPCs
grown in 5% oxygen. However, TSPCs isolated by low-
density plating proliferated more slowly than teno-
Figure 7. Relative expression of osteogenic (A), adipogenic (B), and chondrogenic (C) genes as compared to GAPDH for TSPCs
isolated by differential adhesion onto substrates precoated with 20mg/ml fibronectin (solid fill) or by low density plating at 10 cells/cm2
(hatched fill) and grown in and grown in control (dark gray bars) or osteogenic induction media (light gray bars) and 5% hypoxia. Error
bars represent SEM (n¼3, mean age 10 years, range 1–22 years). ap¼0.034 (interaction), bp¼0.004, cp¼0.013, dp¼0.002, ep¼0.047,
fp¼0.022, gp¼ 0.038, hp¼0.033 (interaction), ip¼ 0.002, jp¼0.001, kp¼0.022 by two-way ANOVA.
856 WILLIAMSON ET AL.
JOURNAL OF ORTHOPAEDIC RESEARCH JUNE 2015
cytes or f-TSPCs in hypoxic conditions (Fig. 3) and had
reduced colony forming ability (Fig. 1D). A previous
report indicated that rabbit TSPCs proliferate faster
than tenocytes,10 however, the tenocyte proliferation
rates were much slower than reported here. This may
be due to the presence of TSPCs in our tenocyte
population, as tenocytes were isolated by direct high
density plating of cells isolated from tendon. Conversely
Zhang et. al. isolated tenocytes from TSPCs by subclon-
ing all colonies from the culture dish and leaving
tenocytes behind. The exercise history of the horses
used in our study was unknown but exercise as well as
species specific difference may also be responsible for
differences in the tenocyte proliferation rates.14
Tendons heal slowly after injury by production of
fibrotic scar tissue. Application of exogenous mesen-
chymal stem cells has been used to attempt to promote
tendon healing, with heterogenous treatment param-
eters and limited outcome measures.31,32 However, the
relatively high proportion of TSPCs reported in tendon
implies that tendons should have an endogenous
regenerative capacity. It may be the case that TSPCs
inappropriately differentiate to alternative lineages
during tendon injury and aging resulting in ectopic
ossification, mucoid degeneration, and fat deposition.
Promoting the retention of a progenitor population
with restricted differentiation potential may therefore
be beneficial for tendon regeneration.
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